Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
𝛼
SK
or Search
SIGN UP
SIGN IN
ENTITY
Chong Kun Dang Pharmaceutical (185750 KS)
Watchlist
24
Analysis
Health Care
•
South Korea
Chong Kun Dang Pharmaceutical Corp. manufactures pharmaceutical products. The Company produces medical drugs in the fields of systemic anti-infective, cardiovascular system, alimentary tract, metabolism, and sensory organs.
more
Watchlist
All
Insights
Primers
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bearish
•
Chong Kun Dang Pharmaceutical
•
29 Aug 2026 23:01
Chong Kun Dang Pharmaceutical (185750 KS): Synthetic Expert Call Transcript (29 Aug 2026)
Succession Tax Optimization Drives Yesterday's Stake Gift: Chairman Lee Jang-han’s sudden gift of his entire 9.55% stake in Chong Kun Dang (CKD)...
αSK SmartScripts
93 Views
Share
bullish
•
Chong Kun Dang Pharmaceutical
•
29 Aug 2026 17:24
Chong Kun Dang Pharmaceutical - Chairman Gifts All His 9.6% Stake to His Children
On 28 August, it was reported that Lee Jang-han (Chairman of Chong Kun Dang Pharm) plans to gift his entire stake in Chong Kun Dang to his three...
Douglas Kim
Follow
95 Views
Share
bullish
•
Chong Kun Dang Pharmaceutical
•
28 Aug 2026 07:42
•
Broker
Chong Kun Dang (185750 KS/Buy)Limited Earnings Improvement, but Pipeline Development on Track
Our target price for Chong Kun Dang is based on the sum of operating value (W1.1tr; revised down from W1.7tr) and pipeline value (W210.7bn).
Mirae Asset Securities
Follow
88 Views
Share
bullish
•
Chong Kun Dang Pharmaceutical
•
26 Aug 2026 07:36
•
Broker
Chong Kun Dang (185750 KS)Limited Earnings Improvement, but Pipeline Development on Track
Our target price for Chong Kun Dang is based on the sum of operating value (W1.1tr; revised down from W1.7tr) and pipeline value (W210.7bn).
Mirae Asset Securities
Follow
93 Views
Share
bullish
•
Chong Kun Dang Pharmaceutical
•
08 Aug 2026 07:01
Primer: Chong Kun Dang Pharmaceutical (185750 KS) - Aug 2026
Chong Kun Dang (CKD) is a leading South Korean pharmaceutical company with a strong domestic franchise, now pivoting towards global expansion...
αSK Primers
88 Views
Share
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
How Smartkarma Compares
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4
x